Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 27, 2007 | Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 300 | $11.39 | 206,879 | |
| Jul 27, 2007 | Director, Ten Percent Owner | Open market or private purchase of non-derivative or derivative security | Form 4 | 300 | $11.39 | 206,879 | |
| Aug 25, 2014 | Chief Operating Officer | Open market or private purchase of non-derivative or derivative security | Form 4 | 7,000 | $6.00 | 207,000 | |
| Oct 01, 2020 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 5,000 | $14.02 | 207,179 | |
| Jul 01, 2020 | Chief Financial Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 13,000 | $2.45 | 207,179 | |
| Jul 01, 2020 | Chief Financial Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 6,872 | $15.47 | 207,179 | |
| Nov 25, 2014 | Chief Operating Officer | Open market or private purchase of non-derivative or derivative security | Form 4 | 7,250 | $8.00 | 207,250 | |
| Jan 10, 2020 | Chief Legal Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 18,728 | $9.46 | 207,450 | |
| Jul 09, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 17,896 | $12.28 | 207,651 | |
| Jan 04, 2021 | Chief Legal Officer | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 33,131 | -- | 208,768 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.